Statistical Profiling of One Promiscuous Protein Binding Site: Illustrated by Urokinase Catalytic Domain

Archive ouverte

Cerisier, Natacha | Regad, Leslie | Triki, Dhoha | Petitjean, Michel | Flatters, Delphine | Camproux, Anne-Claude

Edité par CCSD ; Wiley-VCH -

International audience. While recent literature focuses on drug promiscuity, the characterization of promiscuous binding sites (ability to bind several ligands) remains to be explored. Here, we present a proteochemometric modeling approach to analyze diverse ligands and corresponding multiple binding sub-pockets associated with one promiscuous binding site to characterize protein-ligand recognition. We analyze both geometrical and physicochemical profile correspondences. This approach was applied to examine the well-studied druggable urokinase catalytic domain inhibitor binding site, which results in a large number of complex structures bound to various ligands. This approach emphasizes the importance of jointly characterizing pocket and ligand spaces to explore the impact of ligand diversity on sub pocket properties and to establish their main profile correspondences. This work supports an interest in mining available 3D holo structures associated with a promiscuous binding site to explore its main protein-ligand recognition tendency.

Consulter en ligne

Suggestions

Du même auteur

Cavity Versus Ligand Shape Descriptors: Application to Urokinase Binding Pockets

Archive ouverte | Cerisier, Natacha | CCSD

Gold open access. International audience. We analyzed 78 binding pockets of the human urokinase plasminogen activator (uPA) catalytic domain extracted from a data set of crystallized uPA–ligand complexes. These bind...

Exploring the potential of a structural alphabet-based tool for mining multiple target conformations and target flexibility insight

Archive ouverte | Regad, Leslie | CCSD

International audience. Protein flexibility is often implied in binding with different partners and is essential for protein function. The growing number of macromolecular structures in the Protein Data Bank entries...

Exploration of the effects of sequence variations between HIV-1 and HIV-2 proteases on their three-dimensional structures

Archive ouverte | Triki, Dhoha | CCSD

International audience. HIV protease inhibitors (PIs) approved by the FDA (US Food and Drug Administration) are a major class of antiretroviral. HIV-2 protease (PR2) is naturally resistant to most of them as PIs wer...

Chargement des enrichissements...